Kodiak Sciences

Kodiak Sciences

World Rank (Aug-2026)
5488
Market Cap (Aug-2026)
2.588 Billion USD
Market Cap (Mar-08-2026)
1.490 Billion USD
World Rank (Jan-05-2024)
19,085
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,561
Market Cap (Jul-30-2023)
0.150 Billion USD
World Rank (Jan-07-2022)
4,108
Market Cap (Jan-07-2022)
3.735 Billion USD
World Rank (Jan-01-2021)
2,135
Market Cap (Jan-01-2021)
7.459 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
KOD
Employee Count
85
Employee Count as of Date
As on Sep-2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-234 Million USD
Annual Net Income in USD
-230 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
352 Million USD
Total Liabilities in USD
194 Million USD
Total Equity in USD
157 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
KODIAK SCIENCES
Yahoo
Yahoo @ Nasdaq
Company Profile

Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

Annual Results Summary

KODIAK SCIENCES - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20210-267 (Loss)-266 (Loss)
Dec-20200-136 (Loss)-133 (Loss)
Dec-20190-49 (Loss)-47 (Loss)
Dec-20180-26 (Loss)-41 (Loss)
Founded Year
1996
IPO Year
2018
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share